1. Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
    Md Hossain et al, 2016, Vaccines CrossRef
  2. CpG ODN1826 as a Promising Mucin1-Maltose-Binding Protein Vaccine Adjuvant Induced DC Maturation and Enhanced Antitumor Immunity
    Jing Jie et al, 2018, IJMS CrossRef
  3. Pre-clinical toxicity and immunogenicity evaluation of a MUC1-MBP/BCG anti-tumor vaccine.
    Boqi Hu et al, 2016, Int Immunopharmacol CrossRef
  4. Mycobacterium bovis BCG in metastatic melanoma therapy
    Martha Lucia Ruiz Benitez et al, 2019, Appl Microbiol Biotechnol CrossRef
  5. Designing a Novel Multi-epitope T Vaccine for “Targeting Protein for Xklp-2” (TPX2) in Hepatocellular Carcinoma Based on Immunoinformatics Approach
    Parisa Ghahremanifard et al, 2019, Int J Pept Res Ther CrossRef
  6. Antitumor and immunomodulatory effects of recombinant fusion protein rMBP-NAP through TLR-2 dependent mechanism in tumor bearing mice
    Ting Wang et al, 2015, International Immunopharmacology CrossRef
  7. Mycolicibacterium brumae is a Safe and Non-Toxic Immunomodulatory Agent for Cancer Treatment
    Marc Bach-Griera et al, 2020, Vaccines CrossRef
  8. Mycobacteria-Based Vaccines as Immunotherapy for Non-urological Cancers
    Estela Noguera-Ortega et al, 2020, Cancers CrossRef
  9. Toll‑like receptor agonist rMBP‑NAP enhances antitumor cytokines production and CTL activity of peripheral blood mononuclear cells from patients with lung cancer
    Cong Ding et al, 2018, Oncol Lett CrossRef
  10. A review on development of MUC1-based cancer vaccine.
    Tong Gao et al, 2020, Biomed Pharmacother CrossRef
  11. Mucins as anti-cancer targets: perspectives of the glycobiologist
    Inka Brockhausen et al, 2021, Glycoconj J CrossRef
  12. Optimizing the Expression and Solubilization of an E. coli-Produced Leukemia Inhibitory Factor for Anti-LIF Antibody Production and Use Thereof for Contraception in Mice
    Nahid Mehri et al, 2021, Mol Biotechnol CrossRef
  13. Recombinant MUC1-MBP fusion protein vaccine combined with CpG2006 induces antigen-specific CTL responses through cDC1-mediated cross-priming mainly regulated by type I IFN signaling in mice
    Yu Liu et al, 2022, Immunology Letters CrossRef
  14. Production of recombinant HPV11/16 E6/E7-MBP-His6 fusion proteins and their potential to induce cytokine secretion by immune cells in peripheral blood
    Mei-nian Xu et al, 2024, Virol J CrossRef
  15. MUC1 and MUC16: critical for immune modulation in cancer therapeutics
    Xinyi Chen et al, 2024, Front. Immunol. CrossRef
  16. UCST-Type Soluble Immobilized Cellulase: A New Strategy for the Efficient Degradation and Improved Recycling Performance of Wastepaper Cellulose
    Zhaohui Chen et al, 2024, Molecules CrossRef